Cargando…

Next-Generation Biomarkers for Cholangiocarcinoma

SIMPLE SUMMARY: Early and non-invasive diagnosis of cholangiocarcinoma (CCA) is still challenging, thus largely contributing to the increased mortality rates observed worldwide. Consequently, several efforts have been made in order to report novel biomarkers for CCA, that would aid on diagnosis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodrigues, Pedro M., Vogel, Arndt, Arrese, Marco, Balderramo, Domingo C., Valle, Juan W., Banales, Jesus M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269024/ https://www.ncbi.nlm.nih.gov/pubmed/34203269 http://dx.doi.org/10.3390/cancers13133222

Ejemplares similares

FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next?
por: Saborowski, Anna, et al.
Publicado: (2020)

Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe
por: Beudeker, Boris J.B., et al.
Publicado: (2023)

Heterogeneity of Cholangiocarcinoma Immune Biology
por: Vita, Francesca, et al.
Publicado: (2023)

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
por: Banales, Jesus M., et al.
Publicado: (2020)

Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy
por: Hernández, Alejandra, et al.
Publicado: (2020)

Molecular Subtypes and Precision Oncology in Intrahepatic Cholangiocarcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?
por: Vogel, Arndt, et al.
Publicado: (2014)

Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease
por: Balderramo, Domingo
Publicado: (2022)

Setup of multidisciplinary team discussions for patients with cholangiocarcinoma: current practice and recommendations from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
por: Casadio, M., et al.
Publicado: (2022)

Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
por: Lapitz, Ainhoa, et al.
Publicado: (2023)

Characterizing the Heterogeneity of Liver Cell Populations Under a NASH-Related Hepatotoxicant Using Single-Nuclei RNA Sequencing
por: Rodrigues, Pedro M., et al.
Publicado: (2020)

Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
por: Cesano, Alessandra, et al.
Publicado: (2018)

Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research
por: Erice, Oihane, et al.
Publicado: (2019)

Is necessary to rule out Severe Acute Respiratory Syndrome Coronavirus 2 infection in every patient admitted for acute pancreatitis?
por: Amé, Ricardo Martín, et al.
Publicado: (2022)

Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
por: Lamarca, Angela, et al.
Publicado: (2021)

Targeted Therapies for Perihilar Cholangiocarcinoma
por: Gray, Simon, et al.
Publicado: (2022)

Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma
por: Chan, Jason Yongsheng, et al.
Publicado: (2021)

Next-generation sequencing and biomarkers for gastric cancer: what is the future?
por: Kawazoe, Akihito, et al.
Publicado: (2019)

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
por: Banales, Jesus M., et al.
Publicado: (2019)

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted Therapy
por: Harbin, Laura M., et al.
Publicado: (2022)

Novel approaches in search for biomarkers of cholangiocarcinoma
por: Mocan, Lavinia-Patricia, et al.
Publicado: (2022)

Fecal Fungal Microbiota (Mycobiome) Study as a Potential Tool for Precision Medicine in Inflammatory Bowel Disease
por: Balderramo, Domingo C., et al.
Publicado: (2023)

Intrahepatic Cholangiocarcinoma: A Summative Review of Biomarkers and Targeted Therapies
por: Acher, Alexandra W., et al.
Publicado: (2021)

Melanoma Immunotherapy: Next-Generation Biomarkers
por: Hogan, Sabrina A., et al.
Publicado: (2018)

Next-Generation Nutritional Biomarkers to Guide Better Health Care
por: Redi, CarloAlberto
Publicado: (2016)

Next-generation nutritional biomarkers to guide better health care
por: Mani, Indu, et al.
Publicado: (2017)

Adaptor CAR Platforms—Next Generation of T Cell-Based Cancer Immunotherapy
por: Arndt, Claudia, et al.
Publicado: (2020)

MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort
por: Goble, Spencer, et al.
Publicado: (2023)

Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans
por: Ayoub, Alan, et al.
Publicado: (2023)

Translating Biomarkers of Cholangiocarcinoma for Theranosis: A Systematic Review
por: Wijetunga, Imeshi, et al.
Publicado: (2020)

Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis
por: Lapitz, Ainhoa, et al.
Publicado: (2020)

IAXO, next-generation of helioscopes
por: Giannotti, Maurizio, et al.
Publicado: (2016)

Fourth Generation of Next‐Generation Sequencing Technologies: Promise and Consequences
por: Ke, Rongqin, et al.
Publicado: (2016)

Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development
por: Roth, Sharin E., et al.
Publicado: (2019)

Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?
por: Bourien, Héloïse, et al.
Publicado: (2023)

Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis
por: Soliman, Amro M., et al.
Publicado: (2021)

Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma
por: Zhao, Jemmy, et al.
Publicado: (2023)

Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence
por: Da Fonseca, Leonardo G., et al.
Publicado: (2022)

miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA)
por: Zheng, Bo, et al.
Publicado: (2017)

Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c000k7d5a986vdmn95foakk3q4